Cerapedics, DSM Biomedical collaborate for next-generation peptide bone graft — 5 things to know

Spinal Tech

DSM Biomedical is teaming up with Cerapedics to create the next-generation peptide enhanced bone graft, according to newswiretoday.com.

Here are five things to know:


1. Cerapedics will offer its proprietary synthetic small peptide, P-15, technology and DSM will provide its regenerative materials portfolio.


2. DSM has a bioceramic platform featuring a carbonated apatite matrix.


3. Cerapedics' P-15 technology promotes bone growth from cell attraction to attachment to activation.


4. Cerapedics' i-FACTOR Peptide Enhanced Bone Graft has been on the U.S. market since 2008. i-FACTOR was approved for anterior cervical discectomy and fusion in 2015.


5. The next-generation technology will focus on the lumbar spine.


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers